Read on Twitter
Very encouraging.
Only downside of this vaccine (and Pfizer’s, which is also messenger RNA-based) is that it apparently still needs two doses to achieve this level of protection. https://twitter.com/cnnbrk/status/1328308048402784262
Only downside of this vaccine (and Pfizer’s, which is also messenger RNA-based) is that it apparently still needs two doses to achieve this level of protection. https://twitter.com/cnnbrk/status/1328308048402784262
Side effects appear to be mild — which is good, since many people decide not to return for a second dose if they experience uncomfortable side effects from the first dose.
This thread provides a good analysis of info provided in Moderna’s press release.
The more practical storage requirements for their vaccine formulation definitely gives it an advantage over Pfizer’s. https://twitter.com/nataliexdean/status/1328356823087407105
The more practical storage requirements for their vaccine formulation definitely gives it an advantage over Pfizer’s. https://twitter.com/nataliexdean/status/1328356823087407105
Another good thread on the latest vaccine data...this one pointing out that it’s not yet clear how much protection against SARS-CoV-2 these vaccines will provide *over extended periods of time* https://twitter.com/michaelmina_lab/status/1328357144949886978
